B. Wall

3.0k total citations · 1 hit paper
31 papers, 1.7k citations indexed

About

B. Wall is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cell Biology. According to data from OpenAlex, B. Wall has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Cell Biology. Recurrent topics in B. Wall's work include Neuroscience and Neuropharmacology Research (8 papers), Melanoma and MAPK Pathways (4 papers) and bioluminescence and chemiluminescence research (3 papers). B. Wall is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Melanoma and MAPK Pathways (4 papers) and bioluminescence and chemiluminescence research (3 papers). B. Wall collaborates with scholars based in United States, Germany and Netherlands. B. Wall's co-authors include Suzie Chen, Hwa Jin Lee, Charles M. Roth, Prabhas V. Moghe, Richard E. Riman, Jesse Kohl, Mei Chee Tan, Dominik J. Naczynski, Margot Zevon and James S. Goydos and has published in prestigious journals such as Nature Communications, Cancer Research and Oncogene.

In The Last Decade

B. Wall

30 papers receiving 1.7k citations

Hit Papers

Rare-earth-doped biological composites as in vivo shortwa... 2013 2026 2017 2021 2013 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Wall United States 17 667 516 501 272 227 31 1.7k
Mitsuru Ishikawa Japan 27 1.3k 1.9× 358 0.7× 427 0.9× 334 1.2× 90 0.4× 100 2.4k
Josef Vágner United States 32 2.0k 3.0× 147 0.3× 300 0.6× 380 1.4× 326 1.4× 97 3.1k
Edoardo Micotti Italy 25 386 0.6× 377 0.7× 224 0.4× 169 0.6× 148 0.7× 64 1.8k
Jelena M. Janjic United States 26 475 0.7× 474 0.9× 494 1.0× 193 0.7× 153 0.7× 82 2.3k
Carlos Tassa United States 16 994 1.5× 666 1.3× 546 1.1× 215 0.8× 68 0.3× 21 2.2k
Gene M. Dubowchik United States 26 1.3k 1.9× 125 0.2× 163 0.3× 173 0.6× 719 3.2× 80 3.0k
Xingwu Jiang China 28 612 0.9× 876 1.7× 1.4k 2.7× 97 0.4× 113 0.5× 61 2.3k
Lihong Bu China 20 599 0.9× 484 0.9× 741 1.5× 73 0.3× 126 0.6× 63 2.0k
Ping Huang China 34 1.7k 2.6× 512 1.0× 1.1k 2.1× 191 0.7× 278 1.2× 106 3.5k
Surajit Sinha India 23 1.8k 2.6× 183 0.4× 72 0.1× 144 0.5× 433 1.9× 126 2.6k

Countries citing papers authored by B. Wall

Since Specialization
Citations

This map shows the geographic impact of B. Wall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Wall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Wall more than expected).

Fields of papers citing papers by B. Wall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Wall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Wall. The network helps show where B. Wall may publish in the future.

Co-authorship network of co-authors of B. Wall

This figure shows the co-authorship network connecting the top 25 collaborators of B. Wall. A scholar is included among the top collaborators of B. Wall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Wall. B. Wall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Najjar, Abdulkarim, Sebastien Grégoire, Beate Nicol, et al.. (2025). Grouping of chemicals for safety assessment: the importance of toxicokinetic properties of salicylate esters. Archives of Toxicology. 99(3). 995–1010. 1 indexed citations
2.
Li, Yiming, et al.. (2023). Evaluation of oral and perioral irritation and sensitization potential of a whitening gel and a whitening toothpaste containing potassium monopersulfate.. PubMed. 36(2). 95–100.
3.
Shin, Seung‐Shick, Byeong‐Seon Jeong, B. Wall, et al.. (2018). Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo. Oncogenesis. 7(11). 86–86. 49 indexed citations
4.
Gupta, Soumyasri Das, Misaal Patel, J. Wahler, et al.. (2017). Differential Gene Regulation and Tumor-Inhibitory Activities of Alpha-, Delta-, and Gamma-Tocopherols in Estrogen-Mediated Mammary Carcinogenesis. Cancer Prevention Research. 10(12). 694–703. 11 indexed citations
5.
Yu, Lumeng J., et al.. (2017). Activation of Grm1 expression by mutated BRaf (V600E) in vitro and in vivo. Oncotarget. 9(5). 5861–5875. 6 indexed citations
6.
Yu, Lumeng J., B. Wall, Janet Wangari‐Talbot, & Suzie Chen. (2016). Metabotropic glutamate receptors in cancer. Neuropharmacology. 115. 193–202. 81 indexed citations
7.
Yu, Lumeng J., B. Wall, & Suzie Chen. (2015). The current management of brain metastasis in melanoma: a focus on riluzole. Expert Review of Neurotherapeutics. 15(7). 779–792. 15 indexed citations
8.
Naczynski, Dominik J., Mei Chee Tan, Margot Zevon, et al.. (2013). Rare-earth-doped biological composites as in vivo shortwave infrared reporters. Nature Communications. 4(1). 2199–2199. 653 indexed citations breakdown →
9.
Goraczniak, Rafal, B. Wall, Mark A. Behlke, et al.. (2013). U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo. Molecular Therapy — Nucleic Acids. 2. e92–e92. 5 indexed citations
10.
Lee, Hwa Jin, B. Wall, Janet Wangari‐Talbot, & Suzie Chen. (2012). Regulation of mGluR1 expression in human melanocytes and melanoma cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1819(11-12). 1123–1131. 16 indexed citations
11.
Martino, Jeffrey J., et al.. (2012). Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells. Oncogene. 32(37). 4366–4376. 51 indexed citations
12.
McDonnell, Mark E., Matthew D. Vera, Benjamin E. Blass, et al.. (2012). Riluzole prodrugs for melanoma and ALS: Design, synthesis, and in vitro metabolic profiling. Bioorganic & Medicinal Chemistry. 20(18). 5642–5648. 24 indexed citations
13.
Wangari‐Talbot, Janet, B. Wall, James S. Goydos, & Suzie Chen. (2012). Functional Effects of GRM1 Suppression in Human Melanoma Cells. Molecular Cancer Research. 10(11). 1440–1450. 38 indexed citations
14.
Khan, Atif J., B. Wall, Devora Schiff, et al.. (2011). Riluzole Enhances Ionizing Radiation–Induced Cytotoxicity in Human Melanoma Cells that Ectopically Express Metabotropic Glutamate Receptor 1 In Vitro and In Vivo. Clinical Cancer Research. 17(7). 1807–1814. 34 indexed citations
15.
Shin, Seung‐Shick, B. Wall, James S. Goydos, & Suzie Chen. (2009). AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1). Pigment Cell & Melanoma Research. 23(1). 103–111. 41 indexed citations
16.
Lee, Hwa Jin, B. Wall, & Suzie Chen. (2008). G‐protein‐coupled receptors and melanoma. Pigment Cell & Melanoma Research. 21(4). 415–428. 43 indexed citations
17.
Shin, Seung‐Shick, et al.. (2008). Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation. Pigment Cell & Melanoma Research. 21(3). 368–378. 70 indexed citations
18.
Marín, Yarí E., B. Wall, Su Wang, et al.. (2007). Curcumin downregulates the constitutive activity of NF-κB and induces apoptosis in novel mouse melanoma cells. Melanoma Research. 17(5). 274–283. 92 indexed citations
19.
Bernstein, Ira M., et al.. (1996). Evidence That Normal Fetal Growth Can Be Noncontinuous. Obstetrical & Gynecological Survey. 51(4). 213–214. 10 indexed citations
20.
Lucas, Robert M., Lydia Pleotis Howell, & B. Wall. (1985). Nifedipine‐Induced Gingival Hyperplasia: A Histochemical and Ultrastructural Study. Journal of Periodontology. 56(4). 211–215. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026